ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 4 filers reported holding ALKERMES PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $157,081,873 | -12.9% | 5,608,064 | -2.7% | 5.27% | -9.9% |
Q2 2023 | $180,368,003 | +6.4% | 5,762,556 | -4.2% | 5.85% | +5.5% |
Q1 2023 | $169,518,338 | +16.6% | 6,013,421 | +8.1% | 5.54% | -2.7% |
Q4 2022 | $145,329,991 | +13.5% | 5,561,806 | -3.0% | 5.69% | -1.2% |
Q3 2022 | $128,046,000 | -19.8% | 5,734,259 | +7.0% | 5.76% | -15.0% |
Q2 2022 | $159,606,000 | +15.4% | 5,357,716 | +1.9% | 6.78% | +52.5% |
Q1 2022 | $138,362,000 | +7.4% | 5,258,917 | -5.1% | 4.44% | +27.9% |
Q4 2021 | $128,831,000 | -1.3% | 5,538,740 | +30.9% | 3.47% | -1.0% |
Q3 2021 | $130,523,000 | +779.6% | 4,232,279 | +599.3% | 3.51% | +877.7% |
Q2 2021 | $14,839,000 | +24.3% | 605,180 | -5.3% | 0.36% | +5.6% |
Q1 2021 | $11,941,000 | +1.3% | 639,250 | +8.2% | 0.34% | -0.6% |
Q4 2020 | $11,784,000 | +212.8% | 590,680 | +159.8% | 0.34% | +142.6% |
Q3 2020 | $3,767,000 | -16.1% | 227,350 | -1.7% | 0.14% | -28.8% |
Q2 2020 | $4,488,000 | +159.6% | 231,300 | +92.9% | 0.20% | +96.0% |
Q1 2020 | $1,729,000 | – | 119,900 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |